ESTRELLA IMMUNOPHARMA, INC. (ESLA) Net income 2021–2025
ESTRELLA IMMUNOPHARMA, INC. (ESLA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$13.1MFY2025 · since FY2021: -$247,718 → -$13.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.1M | -78.7% |
| FY2024 | -$7.3M | +34.2% |
| FY2023 | -$11.1M | -1015.8% |
| FY2022 | -$996,104 | -302.1% |
| FY2021 | -$247,718 | — |
Source: SEC XBRL filings · For reference only · Not investment advice